Hedex (Paracetamol Ph. Eur.)

Hedex is an over‑the‑counter medication that contains the active ingredient Paracetamol Ph. Eur. as its sole analgesic component. It is supplied in an oral dosage form, with the specific strength not disclosed in the available product information. Classified under the analgesic/antipyretic therapeutic class, Hedex is marketed within the European Union and follows the standard regulatory specifications for paracetamol products and is intended for short‑term relief of moderate pain and fever.

Hedex is indicated for the temporary relief of common discomforts associated with pain and fever.

- Mild to moderate headache - Minor musculoskeletal aches such as back or joint pain - Fever associated with viral or bacterial infections - Toothache or dental pain - Menstrual cramps - Relief of postoperative discomfort when non‑opioid analgesia is appropriate - Reduction of fever in children over the recommended age and dosage

The safety profile of Hedex reflects the typical experience with paracetamol products, with most users reporting only mild, transient effects.

Common: - Nausea or mild stomach upset - Transient headache - Dizziness or light‑headedness - Skin rash or mild itching - Mild fatigue or drowsiness - Temporary insomnia or sleep disturbance

Serious: - Severe skin reactions such as Stevens‑Johnson syndrome - Acute liver injury, especially with overdose - Anaphylactic or severe allergic reaction - Blood disorders such as thrombocytopenia - Liver failure requiring hospitalization - Kidney impairment in rare cases

When using Hedex, certain precautions help ensure safe and effective use, particularly for individuals with specific health conditions or lifestyle factors.

- Do not exceed the recommended total daily dose of paracetamol. - Avoid use in patients with known severe liver disease. - Use caution when consuming alcohol regularly. - Consult a healthcare professional before use during pregnancy or breastfeeding. - Keep out of reach of children; accidental ingestion can be hazardous. - Review all concurrent medications for potential duplication of paracetamol. - Adjust dose in elderly patients with reduced renal function.

Paracetamol can interact with other substances, influencing its metabolism or increasing the risk of adverse effects. Interactions may affect liver function, blood clotting, or the therapeutic effectiveness of co‑administered drugs.

Avoid: - Concomitant use of other paracetamol‑containing products (risk of overdose). - High‑dose alcohol consumption (enhances liver toxicity). - Certain enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin) that may lower paracetamol levels. - Concurrent use with high‑dose vitamin A supplements (potential hepatotoxicity).

Use with caution: - Warfarin or other anticoagulants (may increase bleeding risk with high doses). - Isoniazid (potential for liver injury). - Rifampicin (may reduce efficacy). - Phenobarbital (enzyme inducer, may reduce effect). - Cholestyramine (may decrease absorption).